<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="23370">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01894113</url>
  </required_header>
  <id_info>
    <org_study_id>TBB2010</org_study_id>
    <nct_id>NCT01894113</nct_id>
  </id_info>
  <brief_title>Prospective, Randomised Multicenter Study Comparing the Efficacy of Transbronchial Forceps Biopsy With Cryobiopsy to Diagnose Interstitial Lung Disease.</brief_title>
  <acronym>TRABIS</acronym>
  <official_title>Prospective, Randomised Multicenter Study Comparing Transbronchial Forceps Biopsy With Cryobiopsy in Interstitial Lung Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Tuebingen</source>
  <oversight_info>
    <authority>Germany: Federal Institute for Drugs and Medical Devices</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The use of cryoprobes improves the diagnostic yield in transbronchial biopsies compared to
      forceps biopsies to diagnose an interstitial lung disease
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Endoscopic biopsy currently plays only a minor role for the diagnosis of interstitial lung
      disease. However, in some cases obtaining lung tissue is necessary to establish a final
      diagnosis. The current standard procedure is transbronchial forceps biopsy - if not
      sufficient: surgical lung biopsy. Transbronchial lung biopsy bears essential limitations
      however:

        -  Small tissue sample

        -  Limited evaluability of the material caused by forceps-induced crush artifacts

      In cryobiopsy the cryoprobe´s tip is being cooled and thereby cools the surrounding tissue
      to approximately minus 89 degrees Celsius. Subsequently, the frozen probe is retracted with
      the frozen tissue being attached onto the frozen probe's tip. When applied in the central
      airways, cryobiopsy proved to deliver large specimens of good quality, which may exceed
      forceps biopsies in terms of diagnostic yield. Pilot studies on transbronchial cryobiopsy
      showed that same advantages as seen in the endobronchial use.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">May 2014</completion_date>
  <primary_completion_date type="Anticipated">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Diagnostic value of each biopsy procedure. It will be identified, how often biopsy contributed to the final diagnosis.</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Differences in the final diagnosis</measure>
    <time_frame>24 Months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Bleeding None, Mild degree (suction &lt;= 3min), Moderate (extraction&gt; 3min), Severe (intervention: tamponade, surgery)</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">382</enrollment>
  <condition>Interstitial Lung Disease</condition>
  <arm_group>
    <arm_group_label>transbronchial forceps lung biopsy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>transbronchial lung biopsy forceps</description>
  </arm_group>
  <arm_group>
    <arm_group_label>transbronchail cryo lung biopsy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>transbronchial lungbiopsy with cryoprobe</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>transbronchial lung biopsy</intervention_name>
    <arm_group_label>transbronchial forceps lung biopsy</arm_group_label>
    <arm_group_label>transbronchail cryo lung biopsy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Clinical indications for biopsy of interstitial lung disease

          2. Age over 18 years

          3. Signed consent

        Exclusion Criteria:

          1. Risk of bleeding / ongoing anticoagulation

          2. Oxygen saturation &lt;90% - despite delivery of 2l oxygen / min

          3. Underlying cardiac disease (unstable angina, myocardial infarction during the last
             month, congestive heart failure)

          4. Pulmonary hypertension, PAP sys&gt; 50mmHg
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jürgen Hetzel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Tuebingen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jürgen Hetzel, MD</last_name>
    <phone>0049-7071-29-82714</phone>
    <email>juergen.hetzel@med.uni-tuebingen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michael Böckeler, MD</last_name>
    <phone>0049-7071-29-82714</phone>
    <email>michael.boeckeler@med.uni-tuebingen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Tuebingen</name>
      <address>
        <city>Tuebingen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juergen Hetzel, MD</last_name>
      <phone>0049-7071-2982714</phone>
      <email>juergen.hetzel@med.uni-tuebingen.de</email>
    </contact>
    <investigator>
      <last_name>Michael Boeckeler, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 11, 2013</lastchanged_date>
  <firstreceived_date>July 2, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Tuebingen</investigator_affiliation>
    <investigator_full_name>Boeckeler, Michael</investigator_full_name>
    <investigator_title>Dr. med. Michael Böckeler</investigator_title>
  </responsible_party>
  <keyword>interstitial lung disease</keyword>
  <keyword>transbronchial biopsy</keyword>
  <keyword>cryobiopsy</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Interstitial</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
